Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma

類似資料

• Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
  著者:: Brandes, Alba A., 等
  出版事項: (2009)
• The impact of concurrent temozolomide with adjuvant radiation and IDH mutation status among patients with anaplastic astrocytoma
  著者:: Kizilbash, Sani H., 等
  出版事項: (2014)
• Temozolomide Salvage Chemotherapy for Recurrent Anaplastic Oligodendroglioma and Oligo-Astrocytoma
  著者:: Gwak, Ho-Shin, 等
  出版事項: (2013)
• Development of Aplastic Anemia during Treatment of Anaplastic Astrocytoma with Temozolomide
  著者:: Khaddour, Karam, 等
  出版事項: (2020)
• Five-year follow-up results for patients diagnosed with anaplastic astrocytoma and effectiveness of concomitant therapy with temozolomide for recurrent anaplastic astrocytoma
  著者:: Sarica, Feyzi Birol, 等
  出版事項: (2012)